Multicellular living organisms and unmodified parts thereof and – Method of introducing a polynucleotide molecule into or... – The polynucleotide alters fat – fatty oil – ester-type wax – or...
Patent
1995-05-08
1999-02-02
McElwain, Elizabeth
Multicellular living organisms and unmodified parts thereof and
Method of introducing a polynucleotide molecule into or...
The polynucleotide alters fat, fatty oil, ester-type wax, or...
800DIG43, 4351723, 4352404, 43524049, 4353201, 536 232, 536 235, A01H 500, C12N 922, C12N 1512, C12N 1582
Patent
active
058667814
ABSTRACT:
Isolated 2-5A-dependent RNases, an interferon-induced enzyme which is activated by 5'-phosphorylated, 2',5'-linked oligoadenylates (2-5A) and implicated in both the molecular mechanisms of interferon action and in the fundamental control of RNA stability in mammalian cells, and encoding sequences therefor are disclosed. The expression cloning and analysis of murine and human 2-5A-dependent RNases is also disclosed. Recombinant human 2-5A-dependent RNase produced in vitro bound an activating affinity matrix, 2-5A-cellulose, resulting in ribonuclease activity. The 2-5A binding properties of the recombinant and naturally occurring forms of 2-5A-dependent RNase are basically identical. Interferon induction of 2-5A-dependent RNase expression is demonstrated by measuring the mRNA levels in cells treated with interferon and cycloheximide. Analysis of aligned murine and human 2-5A-dependent RNase sequences revealed several features, including similarity to RNase E which is implicated in the control of mRNA stability in E. coli. A duplicated phosphate-binding loop motif is determined by deletion analysis and site-directed mutagenesis to function in the binding of 2-5A. In addition, recombinant nucleotide sequences, recombinant vectors, recombinant cells and antiviral plants which express, for example, amino acid sequences which have activity that interfere with or inhibit viral replication are disclosed.
REFERENCES:
patent: 5063159 (1991-11-01), Revel et al.
Jacobsen, H. et al.: Virology, 125:496-501 (1983).
Jacobsen, H. et al.: Proc. Natl. Acad. Sci. USA, 80:4954-4958 (Aug.1983).
Silverman, R.H. et al.: Local Organ. Comm. of 5th Ann. Meeting of Interf. Res. (The Biol. of Interf. Syst. 1988), 183-186 (1989).
Ferbus, D. et al.: Mol. & Cell. Biochem., 62:51-55 (1984).
Eppstein D.A. et al.: J. Biol. Chem., 257(22):13390-13397 (1982).
Hovanessian, A.G. et al.: J. Biol. Chem., 263(10):4945-4949 (1988).
Hovanessian, A.G. et al.: EMBO J., 6(5):1273-1280 (1987).
Hearl, W.G. et al.: J. Virol., 61(5):1586-1592 (1987).
Wreschner, D.H. et al.: Nature, 289(5796):414-417 (Jan. 29, 1981).
Debois, M.F. et al.: Ann. Inst, Pasteur/Virol., 1987.
Silverman, R.H. et al.: J. Biol. Chem.,263(15) 7336-7341 (May 25, 1988).
Yang-Feng, T.L. et al.: Genomics,19:173-176 (1994).
Dong, B. et al.: J. Biol. Chem., 269(19):14153-14158 (May 13, 1994).
Hassel, H.A. et al.: EMBO J., 12(8):3297-3304 (1993).
Zhou, A. et al.: Cell,72:753-765 (Mar. 12, 1993).
William. B.R.G. et al.: Local Org. Comm. of 5th Ann. Meet. of Interf. Res. (The Biol. of Interf. Syst.), 159-162 (1988).
Sawai, H. et al.: J. Biol. Chem., 288(3):1671-1677 (Feb. 10, 1983).
Torrence, P.F. et al.: J. Biol. Chem., 263(3):1131-1139 (Jan. 25, 1988).
Lesiak, K. et al.: J. Biol. Chem., 258(21):13082-13088 (Nov. 10, 1983).
Black, R.J. et al.: FEBS Letters, 191(1):154-158 (Oct. 1985).
Sawai, H. et al.: J. Biol. Chem., 258(3):1671-1677 (Feb. 1, 1983).
Torrence, P.F. et al.: Proc. Natl. Acad. Sci. USA, 78(1):5993-5997 (Oct. 1981).
Lesiak, K. et al.: J. Biol. Chem., 262(5):1961-1965 (Feb. 15, 1987).
Lesiak, K. et al.: Bioconjugate Chem., 467-472 (Nov./Dec., 1993).
Jacobsen, H.J. et al.: Virology, 125:496-501 (1983).
SenGupta, D.N. et al.: Proc. Natl. Acad. Sic. USA, 87:7492-7496 (Oct, 1990).
Silverman, R.H.: Anal. Biochem., 144:450-460 (1985).
Krause, D. et al.: J. Interf. Res., 13:13-16 (1993).
Krause, D. et al.: J. Biol. Chem., 260(16):9501-9507 (Aug. 5, 1985).
Kraus, D. et al.: J. Biol. Chem., 261(15):6836-6839 (May 25, 1986).
Maheshwari, R.K. et al.: Science, 219:1339-1341 (Mar. 18, 1983).
Nolan-Sorden, N.L.: Anal. Biochem., 184:298-304 (1990).
SenGupta, D.N.: Proc. Natl. Acad. Sci. USA, 87:7492-7496 (Oct. 1990).
Silverman, R.H.: Eur. J. Biochem., 126:333-341 (1982).
Ryseicki, G.: J. Interf. Res., 9:649-657 (1989).
Wreschner, D.H. et al.: Nucelic Acids Res., 9(7):1571-1581 (1981).
Cayley, P.J. et al.: Cell. Resp. to Mol. Modul., 347-360.
Torrence, P.F. et al.: Proc. Natl. Acad. Sci. USA, 90:1300-1304 (Feb. 1993).
Silverman, R.H. et al.: Biol. of Interf. System, 189-200 (1983).
Silverman, R.H. et al.: J. Virology, 46(3):1051-1055 (Jun. 1983).
Grimley, P.M. et al.: Cancer Res., 144:3480-3488 (Aug. 1984).
SenGupta, D.N. et al.: Nucleic Acids Res., 17(3):969-978 (1989).
Silverman, R.H.: J. Interf. Res., 14:101-104 (1994).
Kerr, I.M.: Phil. Trans. R. Soc. Lond., B299:59-67 (1982).
Meurs, E. et al.: Ann. Inst. Pasteur/Virol., 137E:251-272 (1986).
Schmidt, A. et al.: Nat. Immun. Cell Growth Regul., 6:19-27 (1987).
Dieffenbach, C.W. et al.: J. Biol. Chem., 264(22):13281-13288 (1989).
Suhadolnik, R.J. et al.: Biochem., 27:8846-8851 (1988).
Wells, J.A. et al.: J. Biol. Chem., 259(2):1363-1370 (Jan. 25, 1984).
Reid, T.R. et al.: Anal. Biochem., 135:000-000 (1983).
Hersh, C.L. et al.: J. Biol. Chem., 259(3):1727-1730 (Feb. 10, 1984).
Iwata, A. et al.: J. Biochem., 104:247-250 (1988).
Shimizu, N. et al.: J. Biochem., 94:1421-1428 (1983).
Orlic, D. et al.: Exp. Hematol., 13:821-826 (1985).
Orlic, D. et al.: Blood Cells, 10:193-210 (1984).
Lewis, J.A. et al.: Viology, 133:464-469 (1984).
Mengheri E. et al.: FEBS, 157(2):301-305 (Jul. 1983).
Lewis, J.A. et al.: Eur. J. Biochem., 86:497-509 (1978).
Lewis, J.A. et al.: Proc. Natl. Acad. Sci. USA, 80:26-30 (Jan. 1983).
Schattner, A. et al.: J. Interf. Res., 1(4):587-594 (1981).
Weissenbach, J. et al.: Proc. natl. Acad. Sci. USA, (77)(12):7152-7156 (Dec. 1980).
Revel, M. et al.: Texas Reports on Biology and Medicine, 41:452-462 (1981-82).
Revel, M.: "Molecular Mechanisms Involved in the Intiviral Effects of Interferon," 101-163.
Revel, M. et al.: Cell. Resp. Mol. Modul., 361-384.
Wallach, D. et al.: Nature, 287:68-90 (Sep.1980).
Revel, M. et al.: Ann. Rev. Biochem., 47:1079-1126 (1978).
Chernajovsky, Y. et al.: Eur. J. Biochem., 96:35-41 (1979).
Wallach, D. et al.: Interferons, 449-463 (1982).
Kimchi, A. et al.: Proc. Natl. Acad. Sci. USA, 76(7):3208-3212 (Jul. 1979).
Kimchi, A. et al.: Anti-Mitogenic Func. of Interf.-Induced (2'-5') Oligo(adenylate . . . , 5-10 (1980).
Ziberstein, A. et al.: Proc. natl. Acad. Sci. USA, 75(1):4734-4738 (Oct. 1978).
Kimchi, A. et al.: FEBS, 134(2):212-216 (Nov. 1981).
Chebath, J. et al.: J. Biol. Chem., 262(8)3852-3857 (Mar. 15, 1987).
Rappoport, S. et al.: FEBS, 149(1):47-50 (Nov. 1982).
Panet, A. et al.: Virology, 114:567-572 (1981).
Epstein, D.A. et al.: Eur. J. Biochem., 118:9-15 (1981).
Sen, G.C.: Pharmac. Ther., 24:235-257 (1984).
Kumar, R. et al.: J. Virol., 62(2)641-643 (Feb. 1988).
Salzberg, S. et al.: Mol. Cell. Biol., 3(10):1759-1765 (Oct. 1983).
Panet, A.: Mol. Cell. Ciochem., 52:153-160 (1983).
Lewis, J.A.: Virology, 162:118-127 (1988).
Neth, R. et al.: Reprint from Modern Trends in Human Leukemia III (Springer-Verlag Berlin Heidelberg Ny 1979).
Kemchi, A. et al.: Nature, 282:20-27 (Dec. 1979).
Sen, G.C. et al.: J. Biol. Chem., 253(17):5915-5921 (Sep. 10, 1978).
Shimizu, N. et al.: J. Biol. Chem., 254(23):12034-12037 (Dec. 10, 1979).
Schmidt, A. et al.: Proc. natl. Acad. Sci. USA, 76(10):4788-4792 (Oct. 1979).
Revel, M. et al.: "Studies on Interef. Action: Synth., Degrad. & Biol. Act of (2'-5')Oligo-Isoadenylate," 1-18.
Lengyel, P. et al.: J. Interf. Res., 7:511-519 (1987).
Floyd-Smith, G. et al.: J. Interf. Res., 8:517-525 (1988).
Kerr, I.M. et al.: Proc. Natl. Acad. Sci. USA, 75(1):256-260 (Jan. 1978).
Salehzada, T. et al.: J. Biol. Chem., 266(9):5808-5813 (Mar. 25, 1991).
Hovanessian, A.G. et al.: Nature, 268:537-538 (Aug. 1977).
Salehzada, T. et al.: Anal. Biochem., 196:410-414 (1991).
Williams, B.R.G. et al.: Nature, 276:88-90 (Nov. 1978).
Roberts, W.K. et al.: Proc. Natl. Acad. Sci. USA, 73(9):3136-3140 (Sep. 1976).
Kerr, I.M. et al.: Nature, 268:537-542.
Salahzada, T. et al.: J. Biol. Chem., 268(11):7733-7740 (Apr.15, 1993).
Lengyel, P.: Proc. Natl. Acad. Sci. USA, 90:5893-5895 (Jul. 1993).
Cayley, P.J. et al.: Piochem. Biophys. Res. Comm., 108(3):1243-1250 (Oct. 15, 1982).
Kerr, I.M. et al.: Eur. J. Biochem., 69:551-561 (1976).
Kumar, R. et al.: J. Virol., 62(9):3175-3181 (Sep. 1988).
Shaila, S. et al.: gen. Virol., 37:535-546 (1977).
Brown, G.E. et al.: Biochem. Biophys. Res.
SenGupta Dibyendu N.
Silverman Robert H.
McElwain Elizabeth
The Cleveland Clinic Foundation
LandOfFree
Antiviral transgenic plants, vectors, cells and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral transgenic plants, vectors, cells and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral transgenic plants, vectors, cells and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1119078